Evidence-Based Medicine Guidelines
Asenapine versus placebo for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Asenapine Versus Placebo for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458482/all/Asenapine_versus_placebo_for_schizophrenia.
Asenapine versus placebo for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/458482/all/Asenapine_versus_placebo_for_schizophrenia. Accessed November 21, 2024.
Asenapine versus placebo for schizophrenia. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458482/all/Asenapine_versus_placebo_for_schizophrenia
Asenapine Versus Placebo for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458482/all/Asenapine_versus_placebo_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Asenapine versus placebo for schizophrenia
ID - 458482
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458482/all/Asenapine_versus_placebo_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
